MGNX vs XEL · rev $39.6M vs P/E 20, $39.33B cap
MacroGenics Inc (MGNX) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
XEL does not have a complete income-statement cache yet.
MGNX currently screens at market cap $246.6M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the MGNX and XEL stock pages for the full models.
Not investment advice.